Grifoparkin®

Active ingredient: Levodopa 250 mg and Carbidopa 25 mg
Therapeutic category: Antiparkinsoniano.
Indications: It is used for the treatment of idiopathic and postencephalic parkinsonism.
Presentation: Box of 30 coated tablets.
Dosage: Consult your physician.